SecBot SecBot
144 ·Filed Nov 2, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed14d 7h ago SEC0001628280-26-068986
Actionable Insight • Neutral

The filings are routine post-vesting sales by officers. The amounts are small and consistent with prior patterns. No material signal for the stock.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$32.00
T+0 close · Nov 2, 2026 · via day close
Latest settled
−14.42%
T+5 · $27.39 · next T+20 in 15d
Vs SPY
−13.83%
α at T+5
Latest observation
−11.21%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $32.00entry
  2. T+1 · 13d ago +6.41%α +4.75% · $34.05
  3. T+5 · 7d ago −14.42%α −13.83% · $27.39
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two officers of Arcutis Biotherapeutics filed Form 144 notices on November 2, 2026, signaling intent to sell shares. Officer Masaru Matsuda plans to sell 1,219 shares (~$38,841) and Officer Patrick Burnett plans to sell 943 shares (~$30,047), both acquired through restricted stock vesting on November 1, 2026. The proposed sales are small relative to the company's $4.0B market cap and the officers' recent prior sales, making this a routine insider transaction with limited market impact.

Key Facts

  • Masaru Matsuda (Officer) filed Form 144 to sell 1,219 shares of common stock, estimated value $38,841.48.
  • Patrick Burnett (Officer) filed Form 144 to sell 943 shares of common stock, estimated value $30,047.19.
  • Both proposed sales are for shares acquired through restricted stock vesting on November 1, 2026.
  • Proposed sale date for both is November 2, 2026, on Nasdaq.
  • Matsuda previously sold 9,989 shares on September 8, 2026 and 3,674 shares on September 16, 2026.
  • Burnett previously sold 8,300 shares on August 11, 2026, 6,700 shares on August 12, 2026, and 1,697 shares on August 19, 2026.
  • Total proposed sale value of ~$68,889 is immaterial relative to Arcutis's $4.0B market cap.
  • Market data shows only 1 insider sell totaling $127K in the prior 30 days.

Financial Impact

Proposed sales total approximately $68,889, representing less than 0.002% of market cap.

dilution

Risk Factors

  • Form 144 is an intent to sell; sales may not occur.
  • Multiple officer sales on the same day could be viewed negatively by some market participants, though amounts are trivial.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (ARQT), Batch item 10001628280-26-068986
Document: 0001628280-26-068986-index.html0001628280-26-068984
Document: 0001628280-26-068986.txt0001628280-26-068986
144 Filing (ARQT), Batch item 40001628280-26-068984
Document: 0001628280-26-068984-index.html0001628280-26-068986
Document: 0001628280-26-068984.txt0001628280-26-068986

Track record

34 reports on ARQT

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
  3. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
  4. Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  5. Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  6. Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
  7. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  8. Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
  10. Nov 2, 202614d ago 144 Neutral 2/10 Viewing Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34

US Market Status

Market Closed · Opens in 8h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026